Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 175

    1.

    Recurrent genital herpes and suppressive oral acyclovir therapy. Relation between clinical outcome and in-vitro drug sensitivity.

    Lehrman SN, Douglas JM, Corey L, Barry DW.

    Ann Intern Med. 1986 Jun;104(6):786-90.PMID: 3010782 [PubMed - indexed for MEDLINE]Related articles

    2.

    In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir-treated patients.

    McLaren C, Corey L, Dekket C, Barry DW.

    J Infect Dis. 1983 Nov;148(5):868-75.PMID: 6313820 [PubMed - indexed for MEDLINE]Related articles

    3.

    Extended acyclovir therapy for herpes genitalis: changes in virus sensitivity and strain variation.

    Lehrman SN, Hill EL, Rooney JF, Ellis MN, Barry DW, Straus SE.

    J Antimicrob Chemother. 1986 Oct;18 Suppl B:85-94.PMID: 3025158 [PubMed - indexed for MEDLINE]Related articles

    4.

    Sensitivity of HSV strains isolated before and after treatment with acyclovir.

    Svennerholm B, Vahlne A, Löwhagen GB, Widell A, Lycke E.

    Scand J Infect Dis Suppl. 1985;47:149-54.PMID: 3006229 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes.

    Straus SE, Seidlin M, Takiff HE, Rooney JF, Felser JM, Smith HA, Roane P, Johnson F, Hallahan C, Ostrove JM, et al.

    Sex Transm Dis. 1989 Apr-Jun;16(2):107-13.PMID: 2545002 [PubMed - indexed for MEDLINE]Related articles

    6.

    Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir.

    Collins P, Oliver NM.

    J Antimicrob Chemother. 1986 Oct;18 Suppl B:103-12.PMID: 3025149 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2.

    Honda M, Okuda T, Hasegawa T, Kurokawa M, Shiraki K, Matsuo K, Komatsuzaki M, Niimura M.

    Antivir Chem Chemother. 2001 Jul;12(4):233-9.PMID: 11771732 [PubMed - indexed for MEDLINE]Related articles

    8.

    Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigs.

    Ellis MN, Barry DW.

    Antimicrob Agents Chemother. 1985 Feb;27(2):167-71.PMID: 2984984 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Isolation of acyclovir-resistant strains of herpes simplex virus from clinical material]

    L'vov ND, Andronova VL, Leont'eva NA, Galegov GA.

    Vopr Virusol. 1999 Nov-Dec;44(6):247-9. Russian. PMID: 10665057 [PubMed - indexed for MEDLINE]Related articles

    10.

    Long-term suppressive therapy with acyclovir for recurrent genital herpes.

    Baker DA.

    J Int Med Res. 1994;22 Suppl 1:24A-31A; discussion 31A-32A.PMID: 8063021 [PubMed - indexed for MEDLINE]Related articles

    12.

    The use of in-vitro sensitivity testing to predict clinical response of recurrent herpes simplex to suppressive oral acyclovir.

    Smith DW, Goodwin CS.

    J Antimicrob Chemother. 1988 May;21(5):657-64.PMID: 3391865 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.

    Peacock JE Jr, Kaplowitz LG, Sparling PF, Durack DT, Gnann JW Jr, Whitley RJ, Lovett M, Bryson YJ, Klein RJ, Friedman-Kien AE, et al.

    Am J Med. 1988 Sep;85(3):301-6.PMID: 3046350 [PubMed - indexed for MEDLINE]Related articles

    14.

    Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.

    Sarisky RT, Bacon TH, Boon RJ, Duffy KE, Esser KM, Leary J, Locke LA, Nguyen TT, Quail MR, Saltzman R.

    Arch Virol. 2003 Sep;148(9):1757-69.PMID: 14505088 [PubMed - indexed for MEDLINE]Related articles

    15.

    Long-term suppression of severe recurrent genital herpes simplex infections with oral acyclovir: a dose-titration study.

    Kroon S, Petersen CS, Andersen LP, Rasmussen JR, Vestergaard BF.

    Genitourin Med. 1990 Apr;66(2):101-4.PMID: 2160423 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.

    Rabella N, Otegui M, Labeaga R, Rodríguez P, Margall N, Gurguí M, Prats G.

    Clin Infect Dis. 2002 Apr 15;34(8):1055-60. Epub 2002 Mar 11.PMID: 11914993 [PubMed - indexed for MEDLINE]Related articles

    17.

    Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins.

    Gold D, Ashley R, Solberg G, Abbo H, Corey L.

    J Infect Dis. 1988 Dec;158(6):1227-34.PMID: 2848900 [PubMed - indexed for MEDLINE]Related articles

    18.

    Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial.

    Mertz GJ, Jones CC, Mills J, Fife KH, Lemon SM, Stapleton JT, Hill EL, Davis LG.

    JAMA. 1988 Jul 8;260(2):201-6.PMID: 3290517 [PubMed - indexed for MEDLINE]Related articles

    19.

    Genital herpes: oral treatment with acyclovir.

    Ruhnek-Forsbeck M.

    Scand J Infect Dis Suppl. 1985;47:63-6.PMID: 3912973 [PubMed - indexed for MEDLINE]Related articles

    20.

    Acyclovir resistance in a patient with chronic mucocutaneous herpes simplex infection.

    Westheim AI, Tenser RB, Marks JG Jr.

    J Am Acad Dermatol. 1987 Nov;17(5 Pt 2):875-80.PMID: 2824577 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data